Abstracts Archive - Page 505 of 1683 - ATC Abstracts

2020 American Transplant Congress
Improvement of Renal Function Prior to Liver Transplantation is Not Associated with Better Long-Term Renal Outcome or Mortality
M. Sterneck¹, T. Horvatits², M. Touma², U. Herden³, A. Lohse², L. Fischer³
¹University Medical Center Hamburg Eppendorf, Hamburg, Germany, ²Department of Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany, ³Transplant Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
*Purpose: Since introduction of the MELD score in the liver allocation system, renal impairment in OLT recipients has become a topic of increasing importance. This…
2020 American Transplant Congress
Simultaneous Liver and Kidney Transplantation—The Lack of Influence of Pre-Formed DSA
A. Bhansali, F. Mahir, M. Facciuto, R. Shapiro, J. Crismale, T. Schiano, G. De Boccardo
Recanati-Miller Transplantation Institute, Mount Sinai Hospital, New York, New York, NY
*Purpose: It is known that renal transplant recipients with preformed donor specific antibodies (DSA) have poorer outcomes associated with episodes of acute rejection (AR) and…
2020 American Transplant Congress
Serum Cystatin C Predicts Kidney-Related Outcomes and Transplant-Free Survival in Patients with End-Stage Liver Disease and Low Body Mass Index
N. Shankar¹, M. Garcia Saenz de Sicilia², A. Duarte-Rojo³, S. K. Asrani⁴, J. F. Trotter⁴, G. B. Klintmalm⁴, B. V. Fischbach⁵, S. A. Gonzalez⁵
¹Internal Medicine, Baylor Scott & White University Medical Center, Dallas, TX, ²University of Arkansas for Medical Sciences, Little Rock, AR, ³Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Center for Liver Diseases, Pittsburgh Liver Research Center, University of Pittsburgh Medical Center, Pittsburgh, PA, ⁴Baylor Simmons Transplant Institute, Dallas, TX, ⁵Baylor Simmons Transplant Institute, Fort Worth, TX
*Purpose: Liver transplant (LT) candidates with sarcopenia are disadvantaged by creatinine-based assessment of renal function as creatinine overestimates glomerular filtration rate (GFR). Low body mass…
2020 American Transplant Congress
Renal Safety of Entecavir and Tenofovir with Hepatitis B Immunoglobulin in Liver Transplant Patients
J. Lee¹, E. Kim¹, S. Yang¹, D. Kim², S. Kim¹, J. Park³, H. Choi⁴, B. Kim³, D. Joo¹, M. Kim¹, S. Kim¹, J. Lee¹
¹Department of Transplantation Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ²Department of Surgery, Wonju Severance Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of, ³Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ⁴Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: Combination of potent nucleos(t)ide analougues (NAs) and hepatitis B immunoglobulin is recommended after liver transplantation for the prevention of hepatitis B virus (HBV) recurrence.…
2020 American Transplant Congress
Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Treatment of Patients with Hepatitis B Following Liver Transplantation
C. Cheng
Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Kwei-Shan Township, Taoyuan, Taiwan
*Purpose: Taiwan has a high prevalence of hepatitis B (HBV) and HBV related end-stages liver diseases are the leading causes of liver transplantation (LT). Tenofovir…
2020 American Transplant Congress
Association with Acute Kidney Injury and Chronic Kidney Disease after Liver Transplantation
R. Ide, M. Ohira, H. Ohdan
Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan
*Purpose: Although early survival after liver transplantation (LT) has improved, late complications such as renal dysfunction have been discussed as a problem. Here, we have…
2020 American Transplant Congress
Clinical Outcomes in Kidney Transplant Recipients Following Implementation of a Strategic Maintenance Reduction Protocol
H. Perkins, K. Foster, N. Patel, H. Meadows, F. Bartlett, C. Perez, J. McGillicuddy, N. Pilch, M. Casey, M. A. Posadas-Salas, D. Taber
Pharmacy, Medical University of South Carolina, Charleston, SC
*Purpose: Post-transplant complications are commonly due to over-immunosuppression, particularly as it relates to infections. The purpose of this study was to assess clinical outcomes in…
2020 American Transplant Congress
Sparing the Nephron in Liver Transplant Recipients with Antithymocyte Bridging: A Four Year Experience
N. Wilson, H. Kuzaro, N. Parrish, S. A. Shah, N. Anwar, R. R. Alloway, S. Tremblay, T. E. Kaiser
U Cincinnati, Cincinnati, OH
*Purpose: Renal function decline after liver transplant (LT) remains a significant issue. Using antithymocyte globulin (rATG) to delay tacrolimus (TAC) initiation may impact renal deterioration;…
2020 American Transplant Congress
Intraoperative Oxygen Delivery and Acute Kidney Injury after Liver Transplantation
W. Kim, H. Lee, H. Yoon, K. Suh
Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Although intraoperative hemodynamic variables were reported to be associated with acute kidney injury (AKI) after liver transplantation, the time-dependent association between intraoperative oxygen delivery…
2020 American Transplant Congress
Management of Hepatic Artery Stenosis Post Liver Transplant
S. Bommena, I. Joshi, P. Kang, T. Chaly, A. Seetharam, N. Patel, M. B. Fallon, S. Mehta
Banner University Medical Center, University of Arizona College of Medicine, Phoenix, AZ
*Purpose: Hepatic Artery Stenosis (HAS) is a significant complication after liver transplantation associated with morbidity. The primary aim of this study is to determine if…